Pharmasset

Therapeutics for the treatment of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)

placePrinceton, New Jersey, United States calendar_todayFounded 1998 groups82 employees language pharmasset.com

Registered entities

Innovation

57 patent families (29 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 6,593 times.

YearFilings
201224
201311
20145
20157
20164
20172
20183
20192
20201
20211

Investor mix

9 investors on record; lead investors include TVM Capital Life Science, Burrill and Company, MSD Capital, TVM; 3 have since exited.

Investor typeCountShare
Venture capital333%
Private equity222%
Other / undisclosed444%
Coming soon